WORK Medical Technology Group LTD (WOK)

WOK Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	3.25	4.09	6.56	1.6	0.73	0.51
Cash & Short-Term Investments	3.25	4.09	6.56	1.6	0.73	0.51
Cash Growth	63.02%	-37.65%	310.85%	118.29%	43.73%	153.84%
Accounts Receivable	1.96	0.62	1.65	3.33	3.29	0.58
Other Receivables	0.02	-	0.17	0.96	0.35	0.4
Receivables	5.09	1.66	4.32	8.74	6.15	6.57
Inventory	1.93	2.46	3.18	4.62	4.36	6.29
Prepaid Expenses	2.53	0.19	0.14	0.02	0.01	0.01
Restricted Cash	-	-	0.4	0.04	0.04	0.36
Other Current Assets	8.78	12.06	6.22	7.13	5.32	4.4
Total Current Assets	21.59	20.46	20.83	22.15	16.61	18.15
Property, Plant & Equipment	16.7	10.61	11.37	6.74	7.98	11.45
Other Intangible Assets	0.95	0.96	1.04	1	0.95	1.06
Long-Term Deferred Tax Assets	-	-	0.11	0.07	-	-
Other Long-Term Assets	0.91	1.13	2.89	-	-	-
Total Assets	48.31	33.16	36.25	29.96	25.54	30.66

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Accounts Payable	1.64	1.72	1.5	3.96	3.2	9.04
Accrued Expenses	2.54	2.49	2.09	2.01	1.61	0.43
Short-Term Debt	6.6	6.39	13.47	9	6.21	6.6
Current Portion of Leases	0.01	0.01	-	0.05	0.02	-
Current Income Taxes Payable	0.52	0.5	0.51	0.74	0.62	0.54
Current Unearned Revenue	0.5	0.4	0.63	0.78	0.74	1.59
Other Current Liabilities	4.02	0.46	1.99	2.39	1.85	0.72
Total Current Liabilities	15.82	11.97	20.18	18.92	14.26	18.91
Long-Term Leases	0.01	0.02	-	0.05	0.07	-
Long-Term Deferred Tax Liabilities	0	0	-	-	0.03	0.35
Total Liabilities	15.83	11.99	20.18	18.97	14.35	19.26

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Common Stock	0	0.05	0.01	0.01	0.01	0.01
Additional Paid-In Capital	27.94	13.04	6.62	0.09	0.09	0.09
Retained Earnings	2.45	5.86	6.98	10.47	10.36	9.49
Comprehensive Income & Other	-0.27	-0.61	-0.41	-0.68	-0.45	0.46
Total Common Equity	30.12	18.34	13.19	9.88	10	10.04
Minority Interest	2.35	2.83	2.88	1.11	1.19	1.35
Shareholders' Equity	32.48	21.16	16.07	10.99	11.19	11.39
Total Liabilities & Equity	48.31	33.16	36.25	29.96	25.54	30.66

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Total Debt	6.62	6.42	13.47	9.1	6.3	6.6
Net Cash (Debt)	-3.37	-2.33	-6.91	-7.5	-5.57	-6.09
Net Cash Growth	-	-	-	-	-	-
Filing Date Shares Outstanding	0.02	0.02	0	0	0	0
Total Common Shares Outstanding	0.02	-	0	0	0	0
Working Capital	5.78	8.48	0.65	3.23	2.35	-0.77
Book Value Per Share	1855.16	-	879061.73	759711.62	769290.08	100400.26
Tangible Book Value	29.17	17.38	12.14	8.88	9.05	8.98
Tangible Book Value Per Share	1796.42	-	809457.60	682907.77	696216.62	89807.12
Buildings	0.33	0.32	0.31	-	-	-
Machinery	6.19	5.64	5.73	12.38	13.09	18.52

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 29, 2026

Data Sources Report a data error